Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate

Abstract : Dexamphetamine (AMPH) is a psychostimulant drug that is used both recreationally and as medication for attention deficit hyperactivity disorder. Preclinical studies have demonstrated that repeated exposure to AMPH can induce damage to nerve terminals of dopamine (DA) neurons. We here assessed the underlying neurobiological changes in the DA system following repeated AMPH exposure and pre-treated rats with AMPH or saline (4 times 5 mg/kg s.c., 2 hours apart), followed by a 1-week washout period. We then used pharmacological MRI (phMRI) with a methylphenidate (MPH) challenge, as a sensitive and non-invasive in-vivo measure of DAergic function. We subsequently validated the DA-ergic changes post-mortem, using a.o. high-performance liquid chromatography (HPLC) and autoradiography. In the AMPH pre-treated group, we observed a significantly larger BOLD response to the MPH challenge, particularly in DA-ergic brain areas and their downstream projections. Subsequent autoradiography studies showed that AMPH pre-treatment significantly reduced DA transporter (DAT) density in the caudate-putamen (CPu) and nucleus accumbens, whereas HPLC analysis revealed increases in the DA metabolite homovanillic acid in the CPu. Our results suggest that AMPH pre-treatment alters DAergic responsivity, a change that can be detected with phMRI in rats. These phMRI changes likely reflect increased DA release together with reduced DAT binding. The ability to assess subtle synaptic changes using phMRI is promising for both preclinical studies of drug discovery, and for clinical studies where phMRI can be a useful tool to non-invasively investigate DA abnormalities, e.g. in neuropsychiatric disorders.
Liste complète des métadonnées

https://hal-normandie-univ.archives-ouvertes.fr/hal-02135218
Contributeur : François Dauphin <>
Soumis le : mardi 21 mai 2019 - 10:13:30
Dernière modification le : mercredi 23 octobre 2019 - 09:57:10

Lien texte intégral

Identifiants

Citation

Anouk Schrantee, Jordi Tremoleda, Marzena Wylezinska-Arridge, Valentine Bouet, Peter Hesseling, et al.. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. PLoS ONE, Public Library of Science, 2017, 12 (2), pp.e0172776. ⟨10.1371/journal.pone.0172776⟩. ⟨hal-02135218⟩

Partager

Métriques

Consultations de la notice

45